{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:42:18Z","timestamp":1775104938880,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04715-6","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:27:19Z","timestamp":1761546439000},"page":"4783-4792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the therapeutic potential of picrosides in breast cancer cell lines: a systematic scoping review"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-9872","authenticated-orcid":false,"given":"Deepika","family":"Soni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasidharan","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1489-1871","authenticated-orcid":false,"given":"Saurabh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"4715_CR1","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.bcp.2006.02.009","volume":"71","author":"BB Aggarwal","year":"2006","unstructured":"Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71:1397\u20131421","journal-title":"Biochem Pharmacol"},{"key":"4715_CR2","doi-asserted-by":"crossref","unstructured":"Almeleebia TM, Alsayari A, Wahab S (2022) Pharmacological and clinical efficacy of Picrorhiza kurroa and its secondary metabolites: a comprehensive review. Mol 27(23):8316","DOI":"10.3390\/molecules27238316"},{"key":"4715_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/0141076815625599","volume":"109","author":"DG Altman","year":"2016","unstructured":"Altman DG, Simera I (2016) A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network. J R Soc Med 109:67\u201377","journal-title":"J R Soc Med"},{"key":"4715_CR4","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/j.suronc.2012.06.001","volume":"21","author":"F Artacho-Cordon","year":"2012","unstructured":"Artacho-Cordon F, Rios-Arrabal S, Lara PC, Artacho-Cordon A, Calvente I, Nunez MI (2012) Matrix metalloproteinases: potential therapy to prevent the development of second malignancies after breast radiotherapy. Surg Oncol 21:e143-151","journal-title":"Surg Oncol"},{"key":"4715_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.phymed.2017.12.001","volume":"39","author":"Y-l Bi","year":"2018","unstructured":"Bi Y-l, Min M, Shen W, Liu Y (2018) Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G 0 \/G 1 cell cycle arrest and regulation of STAT3 signalling pathway. Phytomed: Int J Phytother Phytopharmacol 39:10\u201316","journal-title":"Phytomed: Int J Phytother Phytopharmacol"},{"key":"4715_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1470-2045(07)70074-8","volume":"8","author":"S Cleator","year":"2007","unstructured":"Cleator S, Heller W, Coombes RC (2007) Triple-negative breast cancer: therapeutic options. Lancet Oncol 8:235\u2013244","journal-title":"Lancet Oncol"},{"key":"4715_CR7","doi-asserted-by":"publisher","first-page":"100358","DOI":"10.1016\/j.hermed.2020.100358","volume":"23","author":"P Debnath","year":"2020","unstructured":"Debnath P, Rathore S, Walia S, Kumar M, Devi R, Kumar R (2020) Picrorhiza kurroa: a promising traditional therapeutic herb from higher altitude of western Himalayas. Journal of Herbal Medicine 23:100358","journal-title":"Journal of Herbal Medicine"},{"key":"4715_CR8","doi-asserted-by":"crossref","unstructured":"Hernandes C, Miguita L, de Sales RO, Silva EP, Mendonca POR, Lorencini da Silva B, Klingbeil MFG, Mathor MB, Rangel EB, Marti LC, Coppede JDS, Nunes FD, Pereira AMS, Severino P (2020) Anticancer activities of the quinone-methide triterpenes maytenin and 22-beta-hydroxymaytenin obtained from cultivated Maytenus ilicifolia roots associated with down-regulation of miRNA-27a and miR-20a\/miR-17\u20135p. Mol 25(3):760","DOI":"10.3390\/molecules25030760"},{"key":"4715_CR9","doi-asserted-by":"crossref","unstructured":"Ivanova M, Porta FM, Giugliano F, Frascarelli C, Sajjadi E, Venetis K, Cursano G, Mazzarol G, Guerini-Rocco E, Curigliano G, Criscitiello C, Fusco N (2023) Breast cancer with brain metastasis: molecular insights and clinical management. Genes 14(6):1160","DOI":"10.3390\/genes14061160"},{"key":"4715_CR10","first-page":"627","volume":"15","author":"GA Karikas","year":"2010","unstructured":"Karikas GA (2010) Anticancer and chemopreventing products: some biochemical and therapeutic aspects. J BUON 15:627\u2013638","journal-title":"J BUON"},{"key":"4715_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/1471-2407-9-188","volume":"9","author":"A Kohrmann","year":"2009","unstructured":"Kohrmann A, Kammerer U, Kapp M, Dietl J, Anacker J (2009) Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: new findings and review of the literature. BMC Cancer 9:188","journal-title":"BMC Cancer"},{"key":"4715_CR12","doi-asserted-by":"publisher","first-page":"204173141455711","DOI":"10.1177\/2041731414557112","volume":"5","author":"JK Kular","year":"2014","unstructured":"Kular JK, Basu S, Sharma RI (2014) The extracellular matrix: structure, composition, age-related differences, tools for analysis and applications for tissue engineering. J Tissue Eng 5:2041731414557112","journal-title":"J Tissue Eng"},{"key":"4715_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13562-016-0364-8","volume":"26","author":"V Kumar","year":"2016","unstructured":"Kumar V, Chauhan RS, Tandon C (2016) Biosynthesis and therapeutic implications of iridoid glycosides from Picrorhiza genus: the road ahead. J Plant Biochem Biotechnol 26:1\u201313","journal-title":"J Plant Biochem Biotechnol"},{"key":"4715_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/cbf.2899","volume":"31","author":"C Li","year":"2013","unstructured":"Li C, Guo S, Shi T (2013) Role of NF-kappaB activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells. Cell Biochem Funct 31:263\u2013268","journal-title":"Cell Biochem Funct"},{"key":"4715_CR15","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jnutbio.2004.06.004","volume":"15","author":"JN Losso","year":"2004","unstructured":"Losso JN, Bansode RR, Trappey A 2nd, Bawadi HA, Truax R (2004) In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 15:672\u2013678","journal-title":"J Nutr Biochem"},{"key":"4715_CR16","doi-asserted-by":"publisher","first-page":"109494","DOI":"10.1016\/j.biopha.2019.109494","volume":"120","author":"C Lou","year":"2019","unstructured":"Lou C, Zhu Z, Xu X, Zhu R, Sheng Y, Zhao H (2019) Picroside II, an iridoid glycoside from Picrorhiza kurroa, suppresses tumor migration, invasion, and angiogenesis in vitro and in vivo. Biomed Pharmacother=Biomed Pharmacother 120:109494","journal-title":"Biomed Pharmacother=Biomed Pharmacother"},{"key":"4715_CR17","doi-asserted-by":"publisher","first-page":"517S","DOI":"10.1093\/ajcn\/78.3.517S","volume":"78","author":"R Lui","year":"2003","unstructured":"Lui R (2003) Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nut 78:517S-520S","journal-title":"Am J Clin Nut"},{"key":"4715_CR18","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/mc.20300","volume":"46","author":"Z Mai","year":"2007","unstructured":"Mai Z, Blackburn GL, Zhou JR (2007) Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells. Mol Carcinog 46:534\u2013542","journal-title":"Mol Carcinog"},{"key":"4715_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/513875","volume":"2015","author":"MN Mallick","year":"2015","unstructured":"Mallick MN, Singh M, Parveen R, Khan W, Ahmad S, Zeeshan Najm M, Husain SA (2015) HPTLC analysis of bioactivity guided anticancer enriched fraction of hydroalcoholic extract of Picrorhiza kurroa. Biomed Res Int 2015:1\u201318","journal-title":"Biomed Res Int"},{"key":"4715_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jinorgbio.2016.11.005","volume":"166","author":"JJ Martinez Medina","year":"2017","unstructured":"Martinez Medina JJ, Naso LG, Perez AL, Rizzi A, Ferrer EG, Williams PAM (2017) Antioxidant and anticancer effects and bioavailability studies of the flavonoid baicalin and its oxidovanadium(IV) complex. J Inorg Biochem 166:150\u2013161","journal-title":"J Inorg Biochem"},{"key":"4715_CR21","first-page":"1","volume":"3","author":"M Mukhopadhyay","year":"2012","unstructured":"Mukhopadhyay M, Banerjee P, Nath D (2012) Phytochemicals \u2013 biomolecules for prevention and treatment of human diseases-a review. Int J Sci Eng Res 3:1\u201332","journal-title":"Int J Sci Eng Res"},{"key":"4715_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.tox.2009.10.010","volume":"278","author":"VS Neergheen","year":"2010","unstructured":"Neergheen VS, Bahorun T, Taylor EW, Jen LS, Aruoma OI (2010) Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology 278:229\u2013241","journal-title":"Toxicology"},{"key":"4715_CR23","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Wurbel H (2020) The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol 18:e3000410","journal-title":"PLoS Biol"},{"key":"4715_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrc3204","volume":"12","author":"ND Perkins","year":"2012","unstructured":"Perkins ND (2012) The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer 12:121\u2013132","journal-title":"Nat Rev Cancer"},{"key":"4715_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.fct.2010.11.009","volume":"49","author":"V Rajkumar","year":"2011","unstructured":"Rajkumar V, Guha G, Kumar RA (2011) Antioxidant and anti-neoplastic activities of Picrorhiza kurroa extracts. Food Chem Toxicol: An Int J Publ Br Ind Biol Res Assoc 49:363\u2013369","journal-title":"Food Chem Toxicol: An Int J Publ Br Ind Biol Res Assoc"},{"key":"4715_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.arabjc.2011.01.011","volume":"6","author":"D Rathee","year":"2013","unstructured":"Rathee D, Thanki M, Bhuva S, Anandjiwala S, Agrawal R (2013) Iridoid glycosides-Kutkin, Picroside I, and Kutkoside from Picrorrhiza kurroa Benth inhibits the invasion and migration of MCF-7 breast cancer cells through the down regulation of matrix metalloproteinases. Arab J Chem 6:49\u201358","journal-title":"Arab J Chem"},{"key":"4715_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.compbiolchem.2018.10.017","volume":"78","author":"D Rathee","year":"2019","unstructured":"Rathee D, Lather V, Grewal AS, Dureja H (2019) Enzymatic inhibitory activity of iridoid glycosides from Picrorrhiza kurroa against matrix metalloproteinases: correlating in vitro targeted screening and docking. Comput Biol Chem 78:28\u201336","journal-title":"Comput Biol Chem"},{"key":"4715_CR28","unstructured":"Reunanen N, K\u00e4h\u00e4ri V (2013) Matrix metalloproteinases in cancer cell invasion. In: Madame curie bioscience database [Internet]. Landes Bioscience, Austin (TX)"},{"key":"4715_CR29","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.biopha.2018.11.048","volume":"109","author":"D Soni","year":"2019","unstructured":"Soni D, Grover A (2019) \u201cPicrosides\u201d from Picrorhiza kurroa as potential anti-carcinogenic agents. Biomed Pharmacother=Biomed Pharmacother 109:1680\u20131687","journal-title":"Biomed Pharmacother=Biomed Pharmacother"},{"key":"4715_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12013-024-01281-1","volume":"82","author":"D Soni","year":"2024","unstructured":"Soni D, Anjum Z, Raza K, Verma S (2024a) A review on picrosides targeting NFkappaB and its proteins for treatment of breast cancer. Cell Biochem Biophys 82:575\u2013591","journal-title":"Cell Biochem Biophys"},{"key":"4715_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12032-024-02397-3","volume":"41","author":"D Soni","year":"2024","unstructured":"Soni D, Wahi D, Verma S (2024b) In vitro study on anti-proliferative and anti-cancer activity of picrosides in triple-negative breast cancer. Med Oncol 41:143","journal-title":"Med Oncol"},{"key":"4715_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5530\/pj.2014.2.2","volume":"6","author":"S Suryavanshi","year":"2014","unstructured":"Suryavanshi S, Zanwar A, Hegde M, Kaul-Ghanekar R (2014) Standardization of a polyherbal formulation (HC9) and comparative analysis of its cytotoxic activity with the individual herbs present in the composition in breast cancer cell lines. Pharmacogn J 6:8\u201316","journal-title":"Pharmacogn J"},{"key":"4715_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.matbio.2015.01.005","volume":"44\u201346","author":"SR Van Doren","year":"2015","unstructured":"Van Doren SR (2015) Matrix metalloproteinase interactions with collagen and elastin. Matrix Biol: J Int Soc Matrix Biol 44\u201346:224\u2013231","journal-title":"Matrix Biol: J Int Soc Matrix Biol"},{"key":"4715_CR34","doi-asserted-by":"crossref","unstructured":"Viljoen A, Mncwangi N, Vermaak I (2012) Anti-inflammatory iridoids of botanical origin. Curr Med Chem 19(14):2104\u20132127","DOI":"10.2174\/092986712800229005"},{"key":"4715_CR35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00210-018-1486-4","volume":"391","author":"I Vrhovac Madunic","year":"2018","unstructured":"Vrhovac Madunic I, Madunic J, Antunovic M, Paradzik M, Garaj-Vrhovac V, Breljak D, Marijanovic I, Gajski G (2018) Apigenin, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cells. Naunyn Schmiedebergs Arch Pharmacol 391:537\u2013550","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4715_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2174\/0929867321666141106124315","volume":"22","author":"W Wang","year":"2015","unstructured":"Wang W, Nag SA, Zhang R (2015) Targeting the NF\u03baB signaling pathways for breast cancer prevention and therapy. Curr Med Chem 22:264\u2013289","journal-title":"Curr Med Chem"},{"key":"4715_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA (2022) Triple negative breast cancer: pitfalls and progress. NPJ Breast Cancer 8:95","journal-title":"NPJ Breast Cancer"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04715-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04715-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04715-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:15:58Z","timestamp":1775099758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04715-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4715"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04715-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}